Acts of the General Assembly of Virginia, passed at the session of 1836-37, commencing 5th December, 1836, and ending 31st March, 1837, in the sixty-first year of the Commonwealth.

pt. I. Acts of a public and general nature.--pt. II. Acts of a private and local nature.--[pt. III] Resolutions.

Job training for the homeless : report on demonstration's first year.

"The authors are Lawrence N. Bailis"... [and others]--T.p. verso.

Putting people out of work : first-year growth and employment effects of the Clinton economic plan /

Cover title.

Fanny Dale; or, the first year after marriage. ...

Series from front cover.

Rogeri de Wendover Liber qui dicitur Flores historiarum ab Anno Domini MCLIV. annoque Henrici Anglorum regis secundi primo. The flowers of history by Roger de Wendover: from the year of Our Lord 1154, and the first year of Henry the Second, king of the English.

"The present edition is confined to that portion of Wendover's chronicle which comprises the materials ... collected by himself" [i.e. 1154-1235]--Pref., v. 1.

In our first year of war; messages and addresses to the Congress and the people, March 5, 1917, to January 8, 1918,

"A war volume of the President's messages to follow Why we are at war."--Foreword.

The first year of the war.

Mode of access: Internet.

Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study

Objective: Based on clues from epidemiology and animal experiments, low vitamin D during early life has been proposed as a risk factor for schizophrenia. The aim of this study was to explore the association between the use of vitamin D supplements during the first year of life and risk of developing schizophrenia. Method: Subjects were drawn from the Northern Finland 1966 Birth Cohort (n = 9 114). During the first year of life, data were collected about the frequency and dose of vitamin D supplementation. Our primary outcome measures were schizophrenia, psychotic disorders other than schizophrenia, and nonpsychotic disorders as diagnosed by age 31 years. Males and females were examined separately. Results: In males, the use of either irregular or regular vitamin D supplements was associated with a reduced risk of schizophrenia (Risk ratio (RR) = 0.08, 95% CI 0.01-0.95; RR = 0.12, 95% CI 0.02-0.90, respectively) compared with no supplementation. In males, the use of at least 2000 IU of vitamin D was associated with a reduced risk of schizophrenia (RR = 0.23, 95% CI 0.06-0.95) compared to those on lower doses. There were no significant associations between either the frequency or dose of vitamin D supplements and (a) schizophrenia in females, nor with (b) nonpsychotic disorder or psychotic disorders other than schizophrenia in either males or females. Conclusion: Vitamin D supplementation during the first year of life is associated with a reduced risk of schizophrenia in males. Preventing hypovitaminosis D during early life may reduce the incidence of schizophrenia. (C) 2003 Elsevier B.V. All rights reserved.

First clinical experience with a new non-indwelling voice prosthesis (Provox (R) NID (TM)) for voice rehabilitation after total laryngectomy

Conclusion. The new Provox(R) NID (TM) non- indwelling voice prosthesis investigated in this study provides a good option for laryngectomized patients using non- indwelling voice prostheses and can potentially improve safety and increase patients' satisfaction with their voice and speech. Objective. To investigate the feasibility of and patient satisfaction with the Provox NID non- indwelling voice prosthesis. Material and methods. Pre- and post- study questionnaires were used to evaluate the patients' former voice prosthesis and the Provox NID voice prosthesis. In addition, measurements of pull- out force, maximum phonation time and loudness were made for both voice prostheses. In vitro measurements of airflow characteristics were also made. Following a 6- week trial, all patients provided feedback on the new voice prosthesis and the results were used to further improve the Provox NID. This final version of the new voice prosthesis was subsequently trialled and evaluated by 10 patients 6 months later. Results. Overall results showed that patient satisfaction with the Provox NID non- indwelling voice prosthesis was favourable. The pull- out force for the new prosthesis was significantly higher than that for the formerly used prosthesis and its aerodynamic characteristics were better.